Sparton will conduct design for manufacture and pilot production of pre-commercial instruments for the Resolution System, slated for commercial availability in 4Q 2014.
The Resolution System is the first commercial application of PathoGenetix’s Genome Sequence Scanning (GSS) technology.
It enables pathogen serotype identification and strain typing in five hours from enriched food and clinical samples.
The bacterial strain information is comparable to pulsed field gel electrophoresis (PFGE), the current gold standard for pathogen typing in foodborne illness outbreak investigation and response.
Pre-commercial units of the system are undergoing testing and evaluation by government and food industry partners.